Speaker Profile

PhD, Manager, Field Application Scientists, Ceres Nanosciences

Dr. Lauren Saunders has a Ph.D. in Molecular Biophysics and Biochemistry from Yale University where she specialized in protein kinetics. She completed her postdoc at the National Center for Agricultural Utilization Research focusing on chemical production in yeast and antibiotic discovery in Bacillus sp. She spent several years at Beckman Coulter developing an extensive background in nucleic acid isolation and purification with a wide variety of sample types. She is currently a Field Applications Manager at Ceres Nanosciences specializing in sample preparation for a variety of applications.

A Novel Hydrogel Particle Technology for Purification of cfDNA
Ceres Nanosciences has developed a novel hydrogel particle (Nanotrap particle) functionalized with an affinity bait that binds strongly to cellfree DNA and excludes large DNA fragments. It is integrated into a workflow that highly concentrates cfDNA. We compare this cfDNA isolation with commercially available cfDNA extraction kits.

Clinical Dx Showcase:
Ceres Nanosciences

Ceres Nanosciences' Nanotrap® Particles capture, concentrate, and preserve low-abundance analytes. Our new Nanotrap cfDNA product leverages the Nanotrap hydrogel particle technology in an easy, semi-automated workflow to provide highly concentrated cfDNA with less gDNA.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 9.30 A.M.-1.45 P.M.,Showcase Track S2 - January 25 9.00 A.M.-4.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-2.45 P.M.

The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 18TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required